The Department funds research through the National Institute for Health Research (NIHR). The NIHR currently funds seven active projects with a focus on epilepsy, with a total value of £9,914,239. This figure reflects the total amount of funding allocated to each project for its entire duration. In addition, the NIHR provides infrastructure funding (£512,019 for the period 1 April 2015 to 31 March 2020) to the Cochrane Epilepsy Group, which undertakes a high number of reviews in this area.
The NIHR welcomes funding applications for research into any aspect of human health, including epilepsy. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.
On 21 June 2018, the NIHR launched a global health research call to fund research in three areas, including epilepsy. This call is funded by the Department’s Official Development Assistance allocation.